Effects of leuprolide acetate on adhesion formation and wound healing in the rat model

Journal of the American Association of Gynecologic Laparoscopists

Volumn 8, Issue 1, 2001, Pages 124-128

  Roberts, Jeffrey E ^a   Watkin, Kenneth L ^b   Tulandi, Togas ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; LAPAROTOMY; NONHUMAN; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; RAT; WOUND CLOSURE; WOUND HEALING;

EID: 0035102608     PISSN: 10743804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-3804(05)60561-0     Document Type: Article

References (26)

1. Resolution of chronic pelvic pain after laparoscopic lysis of adhesions
2. Adhesion-related small-bowel obstruction after gynecologic operations
3. Treatment-dependent and treatment-independent pregnancy among women with periadnexal adhesions
4. The cause and prevention of postoperative intraperitoneal adhesions
5. The aetiology of post-operative abdominal adhesions. An experimental study
6. The healing of peritoneum under normal and pathological conditions
7. Serosal hypofibrinolysis, a cause of post-operative adhesions
8. The pathology of peritoneal repair: Its relation to the formation of adhesions
9. Fibrinolytic activity in serosal and synovial membranes
10. The peritoneum. A plea for a change in attitude towards this membrane
11. Use of adhesion prevention barriers in pelvic and reconstructive and gynecologic surgery
12. Pathophysiology of adhesion formation and strategies for prevention
13. Physical barriers in adhesion prevention
14. Role of hypoestrogenism or antiestrogens in adhesion formation after myometrial surgery in primates
15. Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis
16. The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models
17. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: Potential GnRH-a-regulated mechanisms reducing adhesion formation
18. The effects of ovarian hormone deficiency on wound contraction in a rat model
19. Estrogen target cells in the skin
20. Oestradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblast: Immunocytochemical studies
21. Effects of pirfenidone and dermoid cyst fluid on adhesion formation
22. Polyxamer 407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery
23. Extending the use of gonadotropin-releasing hormone agonists: The emerging role of steroidal and nonsteroidal agents
24. Medical treatment of symptomatic endometriosis
25. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment
26. Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: A review